To say that 2020 was an annus horribilis would be an understatement.
But if you had been in a coma for the past twelve months, looking at the activity in university venturing would not give the game away. As you can see in our annual review – and hear from thought leaders from all over the world – spinouts everywhere thrived despite the worst health crisis in living memory.
Biontech and Moderna – two spinouts that long-term readers will have been familiar with years ago – are now household names,…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
